Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neuropace, Inc. - Common Stock
(NQ:
NPCE
)
14.03
+0.43 (+3.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuropace, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
NeuroPace to Present at the Leerink Global Healthcare Conference
March 05, 2026
From
NeuroPace, Inc.
Via
Business Wire
Why NeuroPace Stock Was Inching Higher on Wednesday
↗
March 04, 2026
The company finished 2025 with a convincing pair of earnings beats.
Via
The Motley Fool
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript
↗
March 03, 2026
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
NeuroPace Inc (NASDAQ:NPCE) Beats Q4 2025 Estimates and Reiterates 2026 Outlook
↗
March 03, 2026
Via
Chartmill
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
March 03, 2026
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
February 20, 2026
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
January 13, 2026
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 31, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
December 17, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
December 08, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
December 02, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
November 24, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace (NPCE) Q3 2025 Earnings Call Transcript
↗
November 09, 2025
NeuroPace (NPCE) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
These stocks are moving in today's session
↗
November 05, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
↗
November 05, 2025
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 05, 2025
Via
Benzinga
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
↗
November 05, 2025
Via
Benzinga
Wednesday's session: gap up and gap down stocks
↗
November 05, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
What's going on in today's after hours session
↗
November 04, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
November 04, 2025
From
NeuroPace, Inc.
Via
Business Wire
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
October 23, 2025
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares...
Via
MarketMinute
Topics
Earnings
Supply Chain
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
October 22, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace to Participate in Upcoming Healthcare Conferences
August 28, 2025
From
NeuroPace, Inc.
Via
Business Wire
NeuroPace Revenue Jumps 22 Percent in Q2
↗
August 12, 2025
Via
The Motley Fool
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript
↗
August 12, 2025
Via
The Motley Fool
Topics
Earnings
NeuroPace Reports Record Q2 Revenue
↗
August 12, 2025
Via
The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE
July 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
